Application
MMP9 Antibody (C-term) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the MMP9 antibody detected the MMP9 protein (arrow).| Product Name | MMP9 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MMP9; CLG4B; Matrix metalloproteinase-9; 92 kDa gelatinase; 92 kDa type IV collagenase; Gelatinase B; 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CLG4B |
|---|---|
| Alternative Names | MMP9 CLG4B Matrix metalloproteinase-9 92 kDa gelatinase 92 kDa type IV collagenase Gelatinase B 67 kDa matrix metalloproteinase-9 82 kDa matrix metalloproteinase-9 |
| Molecular Weight(MW) | 78458 Da |
| Function | May play an essential role in local proteolysis of the extracellular matrix and in leukocyte migration. Could play a role in bone osteoclastic resorption. Cleaves KiSS1 at a Gly-|-Leu bond. Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments. Degrades fibronectin but not laminin or Pz-peptide |
| Tissue Specificity | Produced by normal alveolar macrophages and granulocytes |
| Cellular Localization | Secreted, extracellular space, extracellular matrix (Probable) |
| Entrez Gene | 4318 |
|---|---|
| Nucleotide Accession | NP_004985.2 |
Application
MMP9 Antibody (C-term) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the MMP9 antibody detected the MMP9 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
